Importantly, through the analysis of multiple databases, NFE2L3 was found to be strongly correlated with the prognosis of DNA methylation-driven KIRC (Wang et al., 2019; Zhang et al., 2020), indicating its potential as a prognostic biomarker for renal cancer. This evidence concerns the gene NFE2L3 and renal carcinoma.